A citation-based method for searching scientific literature

Kunal Desai, Jeffrey M McManus, Nima Sharifi. Endocr Rev 2021
Times Cited: 6







List of co-cited articles
10 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Integrative genomic profiling of human prostate cancer.
Barry S Taylor, Nikolaus Schultz, Haley Hieronymus, Anuradha Gopalan, Yonghong Xiao, Brett S Carver, Vivek K Arora, Poorvi Kaushik, Ethan Cerami, Boris Reva,[...]. Cancer Cell 2010
50

Abiraterone and increased survival in metastatic prostate cancer.
Johann S de Bono, Christopher J Logothetis, Arturo Molina, Karim Fizazi, Scott North, Luis Chu, Kim N Chi, Robert J Jones, Oscar B Goodman, Fred Saad,[...]. N Engl J Med 2011
33

Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.
R Bruce Montgomery, Elahe A Mostaghel, Robert Vessella, David L Hess, Thomas F Kalhorn, Celestia S Higano, Lawrence D True, Peter S Nelson. Cancer Res 2008
963
33

Immunotherapy and Immunotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer.
Dhruv Bansal, Melissa A Reimers, Eric M Knoche, Russell K Pachynski. Cancers (Basel) 2021
8
33

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer.
Karim Fizazi, NamPhuong Tran, Luis Fein, Nobuaki Matsubara, Alfredo Rodriguez-Antolin, Boris Y Alekseev, Mustafa Özgüroğlu, Dingwei Ye, Susan Feyerabend, Andrew Protheroe,[...]. N Engl J Med 2017
925
33

Integrative clinical genomics of advanced prostate cancer.
Dan Robinson, Eliezer M Van Allen, Yi-Mi Wu, Nikolaus Schultz, Robert J Lonigro, Juan-Miguel Mosquera, Bruce Montgomery, Mary-Ellen Taplin, Colin C Pritchard, Gerhardt Attard,[...]. Cell 2015
33

Cancer Statistics, 2021.
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
33

AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.
Emmanuel S Antonarakis, Changxue Lu, Hao Wang, Brandon Luber, Mary Nakazawa, Jeffrey C Roeser, Yan Chen, Tabrez A Mohammad, Yidong Chen, Helen L Fedor,[...]. N Engl J Med 2014
33

Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer.
Arun A Azad, Stanislav V Volik, Alexander W Wyatt, Anne Haegert, Stephane Le Bihan, Robert H Bell, Shawn A Anderson, Brian McConeghy, Robert Shukin, Jenny Bazov,[...]. Clin Cancer Res 2015
303
33



Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast Cancer.
Diana C West, Masha Kocherginsky, Eva Y Tonsing-Carter, D Nesli Dolcen, David J Hosfield, Ricardo R Lastra, Jason P Sinnwell, Kevin J Thompson, Kathleen R Bowie, Ryan V Harkless,[...]. Clin Cancer Res 2018
24
16

Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer.
Philip A Watson, Vivek K Arora, Charles L Sawyers. Nat Rev Cancer 2015
606
16

Deep androgen receptor suppression in prostate cancer exploits sexually dimorphic renal expression for systemic glucocorticoid exposure.
M Alyamani, J Li, M Patel, S Taylor, F Nakamura, M Berk, C Przybycin, E M Posadas, R A Madan, J L Gulley,[...]. Ann Oncol 2020
10
16

Comparing the rules of engagement of androgen and glucocorticoid receptors.
Frank Claessens, Steven Joniau, Christine Helsen. Cell Mol Life Sci 2017
24
16

Olaparib for Metastatic Castration-Resistant Prostate Cancer.
Johann de Bono, Joaquin Mateo, Karim Fizazi, Fred Saad, Neal Shore, Shahneen Sandhu, Kim N Chi, Oliver Sartor, Neeraj Agarwal, David Olmos,[...]. N Engl J Med 2020
405
16

Development of a second-generation antiandrogen for treatment of advanced prostate cancer.
Chris Tran, Samedy Ouk, Nicola J Clegg, Yu Chen, Philip A Watson, Vivek Arora, John Wongvipat, Peter M Smith-Jones, Dongwon Yoo, Andrew Kwon,[...]. Science 2009
16

Steroid biomarkers and genetic studies reveal inactivating mutations in hexose-6-phosphate dehydrogenase in patients with cortisone reductase deficiency.
Gareth G Lavery, Elizabeth A Walker, Ana Tiganescu, Jon P Ride, Cedric H L Shackleton, Jeremy W Tomlinson, John M C Connell, David W Ray, Anna Biason-Lauber, Ewa M Malunowicz,[...]. J Clin Endocrinol Metab 2008
51
16

Targeting the glucocorticoid receptor in breast and prostate cancers.
Jacob Kach, Suzanne D Conzen, Russell Z Szmulewitz. Sci Transl Med 2015
38
16

Novel H6PDH mutations in two girls with premature adrenarche: 'apparent' and 'true' CRD can be differentiated by urinary steroid profiling.
G G Lavery, J Idkowiak, M Sherlock, I Bujalska, J P Ride, K Saqib, M F Hartmann, B Hughes, S A Wudy, J De Schepper,[...]. Eur J Endocrinol 2013
29
16

Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer.
Masis Isikbay, Kristen Otto, Steven Kregel, Jacob Kach, Yi Cai, Donald J Vander Griend, Suzanne D Conzen, Russell Z Szmulewitz. Horm Cancer 2014
143
16

Androgen Signaling in Prostate Cancer.
Charles Dai, Hannelore Heemers, Nima Sharifi. Cold Spring Harb Perspect Med 2017
114
16

Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial.
Huw D Thomas, Christopher R Calabrese, Michael A Batey, Stacie Canan, Zdenek Hostomsky, Suzanne Kyle, Karen A Maegley, David R Newell, Donald Skalitzky, Lan-Zhen Wang,[...]. Mol Cancer Ther 2007
201
16


Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets.
Claire E Knezevic, Gabriela Wright, Lily L Remsing Rix, Woosuk Kim, Brent M Kuenzi, Yunting Luo, January M Watters, John M Koomen, Eric B Haura, Alvaro N Monteiro,[...]. Cell Chem Biol 2016
50
16

Hexose-6-phosphate dehydrogenase knock-out mice lack 11 beta-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation.
Gareth G Lavery, Elizabeth A Walker, Nicole Draper, Pancharatnam Jeyasuria, Josep Marcos, Cedric H L Shackleton, Keith L Parker, Perrin C White, Paul M Stewart. J Biol Chem 2006
167
16

HSD3B1 genotype identifies glucocorticoid responsiveness in severe asthma.
Joe Zein, Benjamin Gaston, Peter Bazeley, Mark D DeBoer, Robert P Igo, Eugene R Bleecker, Deborah Meyers, Suzy Comhair, Nadzeya V Marozkina, Calvin Cotton,[...]. Proc Natl Acad Sci U S A 2020
12
16

Steroid receptors aplenty in prostate cancer.
Nima Sharifi. N Engl J Med 2014
27
16

Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer.
Kai-Hsiung Chang, Rui Li, Mahboubeh Papari-Zareei, Lori Watumull, Yan Daniel Zhao, Richard J Auchus, Nima Sharifi. Proc Natl Acad Sci U S A 2011
241
16

Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors.
Ann-Gerd Thorsell, Torun Ekblad, Tobias Karlberg, Mirjam Löw, Ana Filipa Pinto, Lionel Trésaugues, Martin Moche, Michael S Cohen, Herwig Schüler. J Med Chem 2017
146
16

Hexose-6-phosphate dehydrogenase: linking endocrinology and metabolism in the endoplasmic reticulum.
Gábor Bánhegyi, Miklós Csala, Angelo Benedetti. J Mol Endocrinol 2009
34
16

Steroidogenic Metabolism of Galeterone Reveals a Diversity of Biochemical Activities.
Mohammad Alyamani, Zhenfei Li, Michael Berk, Jianneng Li, Jingjie Tang, Sunil Upadhyay, Richard J Auchus, Nima Sharifi. Cell Chem Biol 2017
27
16

Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1.
Iwona J Bujalska, Nicole Draper, Zoi Michailidou, Jeremy W Tomlinson, Perrin C White, Karen E Chapman, Elizabeth A Walker, Paul M Stewart. J Mol Endocrinol 2005
136
16

Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer.
Jianneng Li, Mohammad Alyamani, Ao Zhang, Kai-Hsiung Chang, Michael Berk, Zhenfei Li, Ziqi Zhu, Marianne Petro, Cristina Magi-Galluzzi, Mary-Ellen Taplin,[...]. Elife 2017
52
16

Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study.
Wassim Abida, David Campbell, Akash Patnaik, Jeremy D Shapiro, Brieuc Sautois, Nicholas J Vogelzang, Eric G Voog, Alan H Bryce, Ray McDermott, Francesco Ricci,[...]. Clin Cancer Res 2020
111
16

Glucocorticoids and prostate cancer treatment: friend or foe?
Bruce Montgomery, Heather H Cheng, James Drechsler, Elahe A Mostaghel. Asian J Androl 2014
29
16

Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade.
Vivek K Arora, Emily Schenkein, Rajmohan Murali, Sumit K Subudhi, John Wongvipat, Minna D Balbas, Neel Shah, Ling Cai, Eleni Efstathiou, Chris Logothetis,[...]. Cell 2013
544
16

Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer.
Zhenfei Li, Andrew C Bishop, Mohammad Alyamani, Jorge A Garcia, Robert Dreicer, Dustin Bunch, Jiayan Liu, Sunil K Upadhyay, Richard J Auchus, Nima Sharifi. Nature 2015
175
16

Androgen-glucocorticoid interactions in the era of novel prostate cancer therapy.
Sujata Narayanan, Sandy Srinivas, David Feldman. Nat Rev Urol 2016
46
16

Sex Hormones and Prostate Cancer.
Richard J Auchus, Nima Sharifi. Annu Rev Med 2020
20
16

Glucocorticoids promote breast cancer metastasis.
Milan M S Obradović, Baptiste Hamelin, Nenad Manevski, Joana Pinto Couto, Atul Sethi, Marie-May Coissieux, Simone Münst, Ryoko Okamoto, Hubertus Kohler, Alexander Schmidt,[...]. Nature 2019
128
16

A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer.
Kai-Hsiung Chang, Rui Li, Barbara Kuri, Yair Lotan, Claus G Roehrborn, Jiayan Liu, Robert Vessella, Peter S Nelson, Payal Kapur, Xiaofeng Guo,[...]. Cell 2013
195
16

Direct Metabolic Interrogation of Dihydrotestosterone Biosynthesis from Adrenal Precursors in Primary Prostatectomy Tissues.
Charles Dai, Yoon-Mi Chung, Evan Kovac, Ziqi Zhu, Jianneng Li, Cristina Magi-Galluzzi, Andrew J Stephenson, Eric A Klein, Nima Sharifi. Clin Cancer Res 2017
19
16

Clinical and Biological Characterisation of Localised High-risk Prostate Cancer: Results of a Randomised Preoperative Study of a Luteinising Hormone-releasing Hormone Agonist with or Without Abiraterone Acetate plus Prednisone.
Eleni Efstathiou, John W Davis, Louis Pisters, Weimin Li, Sijin Wen, Ryan P McMullin, Michael Gormley, Deborah Ricci, Mark Titus, Anh Hoang,[...]. Eur Urol 2019
13
16

Improved vectors and genome-wide libraries for CRISPR screening.
Neville E Sanjana, Ophir Shalem, Feng Zhang. Nat Methods 2014
16

Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy.
Zhenfei Li, Mohammad Alyamani, Jianneng Li, Kevin Rogacki, Mohamed Abazeed, Sunil K Upadhyay, Steven P Balk, Mary-Ellen Taplin, Richard J Auchus, Nima Sharifi. Nature 2016
101
16

Direct protein-protein interaction of 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the endoplasmic reticulum lumen.
Atanas G Atanasov, Lyubomir G Nashev, Laurent Gelman, Balazs Legeza, Ragna Sack, Reto Portmann, Alex Odermatt. Biochim Biophys Acta 2008
43
16

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study.
V Conteduca, D Wetterskog, M T A Sharabiani, E Grande, M P Fernandez-Perez, A Jayaram, S Salvi, D Castellano, A Romanel, C Lolli,[...]. Ann Oncol 2017
159
16


Expression of luteinizing hormone releasing hormone and its mRNA in human endometrial cancer cell lines.
G Irmer, C Bürger, O Ortmann, K D Schulz, G Emons. J Clin Endocrinol Metab 1994
56
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.